top of page
Brian Oscherwitz Headshot.jpg


COO, Kinexum

Brian Oscherwitz has over 20 years of experience working alongside executive leadership to direct cross-functional teams of subject matter experts. He has led teams in the completion of a wide range of projects, including new product development, commercial launch programs, global regulatory filings, process improvement initiatives, and portfolio and corporate integrations.

Brian’s project management expertise spans several areas, including directing the clinical operations of several pharmaceutical companies. As a member of Shire Pharmaceuticals’ Clinical Operational Excellence & Support team, Brian led a novel Risk Management & Clinical Trial Oversight model designed to transform global Clinical Operations while enhancing comprehensive project quality and ICH E6 R2 compliance. Brian also led generic clinical development programs for Biovail Technologies, Inc., and for development/clinical-stage companies Reata Pharmaceuticals and Constellation Pharmaceuticals.

Brian provides Kinexum with insight gained from his experience leading teams of contributors with roles ranging from Clinical Research Associate to CEO; and representing a multitude of operational disciplines worldwide. Brian’s experience in developing and leading project initiatives – from pre-clinical to launch – for clients across the CRO, patient recruitment/retention, consumer product, pharmaceutical, and biotech sectors also spans from startup to big pharma.

Brian received his MBA with a concentration in the Management of Technology from The University of Texas at San Antonio, and his BA in Microbiology with an emphasis on Immunology from The University of Texas at Austin. Brian is also PMP-certified through the Project Management Institute (PMI).

bottom of page